Stereotaxis Launches Hungary’s First Robotic Cardiology Program
ST. LOUIS, Missouri, USA | July 20, 2026 Stereotaxis announced the launch of Hungary’s first advanced robotic cardiology program...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ST. LOUIS, Missouri, USA | July 20, 2026 Stereotaxis announced the launch of Hungary’s first advanced robotic cardiology program...
IRVINE, Calif., July 8, 2026 Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA)...
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
Austin, Texas, USA — May 22, 2026 The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center has...
San Francisco, California, USA – April 22, 2026 In a significant advancement for rare cardiac disease therapeutics, Thryv Therapeutics...
LAGUNA HILLS, Calif., March 19, 2026 Adagio Medical Holdings, Inc. announced successful outcomes from Expanded Access Program (EAP) cases...
